openPR Logo
Press release

Pharmacovigilance and Drug Safety Software Market: Increasing Withdrawals of High-profile Drugs Make Way for Growth

11-09-2018 12:48 PM CET | Health & Medicine

Press release from: Transparency Market Research

Pharmacovigilance and Drug Safety Software Market: Increasing

The global pharmacovigilance and drug safety software market is foretold to be advantaged by the soaring incidences of adverse drug reaction (ADR) and increasing adoption of related software services by numerous outsourcing firms. Market shares could continue to expand with the mounting pressure on pharma and biotech makes to produce safe drugs. Government entities such as European Medicines Evaluation Agency (EMEA) and the U.S. Food and Drug Administration (FDA) could be among the prominent organizations increasing the pressure.

Read Report Overview @

The global pharmacovigilance and drug safety software market is envisioned to rise at a 5.4% CAGR between 2017 and 2022 to attain a valuation of US$187.0 mn by the end of the forecast timeframe. In 2017, the market earned a US$143.6 mn.

As per the analysis of the report, the world pharmacovigilance and drug safety software market could testify the lead secured by adverse event reporting software throughout the course of the forecast period. By 2022 end, this software type segment could post a revenue of US$77.0 mn. Other segments such as fully integrated software, issue tracking software, and drug safety audits software could also make their contribution to the market.

In view of end user, there could be business opportunities created by business process outsourcing (BPO) firms, contract research organizations (CROs), pharma and biotech companies, and other pharmacovigilance service providers operating in the world pharmacovigilance and drug safety software market. With respect to delivery mode, players could focus on two vital segments, viz. on-premise and cloud-based.

A comprehensive study of important segments of the world pharmacovigilance and drug safety software market could help players to take advantage of prospects currently available and even those foreseen to take shape in the near future.

Request for the Sample Report @

In terms of geography, the international pharmacovigilance and drug safety software market is anticipated to be classified into six segments, including Latin America, amongst which North America could hold a king’s share while rising at a 6.2% CAGR. This region could also be an attractive market for pharmacovigilance and drug safety software as it is forecasted to dominate with its higher revenue growth until the end of 2022.

During the course of the forecast timeframe, Europe could produce an absolute revenue opportunity of US$9.3 mn. Asia Pacific except Japan (APEJ) is predicted to tread upon the heels of Europe by creating an opportunity of US$8.5 mn during the same timeframe. Japan could showcase a slower growth in the market by garnering a projected revenue of US$13.4 mn by the end of 2022. The Middle East and Africa (MEA) is prophesied to expand at a slightly lower CAGR than that of Japan.

The worldwide pharmacovigilance and drug safety software market could include prominent players such as UMBRA Global LLC, AB Cube, United BioSource Corporation, Sparta Systems, Inc., and Oracle Corporation. Acquisition of new companies, collaborations, joint ventures, and constant upgradation are envisaged to be top business strategies adopted by chief players in the market.

Obtain the Report Brochure @

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance and Drug Safety Software Market: Increasing Withdrawals of High-profile Drugs Make Way for Growth here

News-ID: 1358865 • Views: 134

More Releases from Transparency Market Research

Voltage Detectors Market – Evolving Technology Trends and Industry SWOT Analys …
The global voltage detectors market includes large number of players. Some of the key players are Texas Instruments, Toshiba, ROHM Semiconductor Sharp Microelectronics, Analog Devices Inc., STMicroelectronics, ON Semiconductor, Torex Semiconductor, Taiwan Semiconductor and Seiko Instruments. Browse Our Report @ Voltage Detector is a testing equipment generally used to determine the existence or absence of an electrical charge in an object. It is highly suggested for conditions where power issues exist.
Switched Capacitor Filters Market : Key Segments, Maket Insights, Regional Outlo …
Major players in the global switched capacitor filters market are Texas Instruments Incorporated, Analog Devices, Inc., Maxim Integrated, Inc., Siemens AG, Eaton Corporation, and among others. Browse Our Report @ A switched capacitor filter is an active filter based on the consideration that a switching of capacitors between two circuit nodes at an adequately high rate that is equivalent to a resistor connecting these two nodes. The switched capacitor filters are
Current Calibrator Market : Recent Industry Developments And Growth Strategies A …
Key players operating in the global current calibrator market include Valhalla Scientific, Rotek Inc., Time Electronics, PCE Instruments, Martel Electronics, AOIP Instrumentation, Extech Instruments, Yogokawa Test & Measurement Corporation, Extech Instruments, REED Instruments, Fluke Corporation, and others. These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the
Damp Meter Market – Outlook by Responsible Drivers, Restraints, Demand
Key players operating in the global damp meter market include PCE Instrument, Delmhorst Instrument Co., GENERAL TOOLS & INSTRUMENTS LLC, FLIR Systems, Inc. designs, Panomex Inc., These players are actively focusing on organic and inorganic growth strategies in order to gain a competitive advantage in the market. Some of the important strategies adopted by the leading players in the global market are collaborations, partnerships, agreements, and new product launches. The

All 5 Releases

More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample - Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning